Despite relatively low frequency of TP53 mutations in de novo acute myeloid leukemia – rearrangement of the short arm of chromosome 17 (locating TP53) or TP53 gene mutations are frequently observed in AML with myelodysplasia-related changes and post-cytotoxic changes [19]. This evidence concerns the gene TP53 and Myelodysplasia.